Role of Krüppel-Like factor 2 and protease-activated receptor-1 in vulnerable plaques of ApoE-/- mice and intervention with statin

Canadian Journal of Cardiology

Volumn 29, Issue 8, 2013, Pages 997-1005

  Yang, Lixia ^a   Zhou, Xiaobin ^a   Guo, Ruiwei ^a   Shi, Yankun ^a   Liang, Xing ^a   Heng, Xuhua ^a  

^a KUNMING GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KRUPPEL LIKE FACTOR 2; PROTEINASE ACTIVATED RECEPTOR 1;

ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTIMA; KNOCKOUT GENE; LIPID DIET; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; PYRROLES; RECEPTOR, PAR-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84881030042     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.11.012     Document Type: Article

References (30)

1. Stone G.W., Maehara A., Lansky A.J., et al. Aprospective natural-history study of coronary atherosclerosis. NEngl J Med 2011, 364:226-235.
2. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
3. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. JCell Physiol 2001, 188:143-160.
4. Mahabeleshwar G.H., Kawanami D., Sharma N., et al. The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock. Immunity 2011, 34:715-728.
5. Lin Z. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005, 96:e48-e57.
6. Hergenreider E., Heydt S., Treguer K., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14:249-256.
7. Atkins G.B., Wang Y., Mahabeleshwar G.H., et al. Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis. Circ Res 2008, 103:690-693.
8. Lingrel J.B., Pilcher-Roberts R., Basford J.E., et al. Myeloid-specific Kruppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis. Circ Res 2012, 110:1294-1302.
9. Rossi J., Rouleau L., Tardif J.C., Leask R.L. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Life Sci 2010, 87:92-99.
10. Lin Z., Hamik A., Jain R., Kumar A., Jain M.K. Kruppel-like factor 2inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol 2006, 26:1185-1189.
11. Kosoglou T., Reyderman L., Tiessen R.G., et al. Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects. Eur J Clin Pharmacol 2012, 68:249-250.
12. Sorensen S.D., Nicole O., Peavy R.D., et al. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol 2003, 64:1199-1209.
13. Osuga Y., Hirota Y., Taketani Y. Basic and translational research on proteinase-activated receptors: proteinase-activated receptors in female reproductive tissues and endometriosis. JPharmacol Sci 2008, 108:422-425.
14. van Hinsbergh V.W. Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol 2012, 34:93-106.
15. Abdallah M.H., Karrowni W., Dakik H.A. Profound regression of coronary atherosclerosis with statins. Can J Cardiol 2006, 22:709.
16. Williams H., Johnson J.L., Carson K.G., Jackson C.L. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002, 22:788-792.
17. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. NEngl J Med 1997, 336:1276-1282.
18. Virmani R., Burke A., Farb A. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. Eur Heart J 1998, 19:678-680.
19. Wu J., Srinivasan S.V., Neumann J.C., Lingrel J.B. The KLF2 transcription factor does not affect the formation of preadipocytes but inhibits their differentiation into adipocytes. Biochemistry 2005, 44:11098-11105.
20. Lee H., Kang R., Kim Y.S., Chung S.I., Yoon Y. Platycodin D inhibits adipogenesis of 3T3-L1 cells by modulating Kruppel-like factor 2 and peroxisome proliferator-activated receptor gamma. Phytother Res 2010, 24(suppl 2):S161-S167.
21. Mack P.J., Zhang Y., Chung S., Vickerman V., Kamm R.D., Garcia-Cardena G. Biomechanical regulation of endothelium-dependent events critical for adaptive remodeling. JBiol Chem 2009, 284:8412-8420.
22. Tellez C., McCarty M., Ruiz M., Bar-Eli M. Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. JBiol Chem 2003, 278:46632-46642.
23. Cheng C.Y., Sun Y., Wen Z.B., et al. Effects of tetramethylpyrazine on thrombin-induced tissue factor expression in vascular endothelial cells. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:1743-1747. [in Chinese].
24. Diebold I., Djordjevic T., Hess J., Gorlach A. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost 2008, 100:1021-1028.
25. Chen D., Carpenter A., Abrahams J., et al. Protease-activated receptor 1activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment invivo. JExp Med 2008, 205:1739-1746.
26. Bu D.X., Tarrio M., Grabie N., et al. Statin-induced Kruppel-like factor 2expression in human and mouse T cells reduces inflammatory and pathogenic responses. JClin Invest 2010, 120:1961-1970.
27. Banfi C., Brioschi M., Lento S., et al. Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells invitro. JThromb Haemost 2011, 9:1608-1619.
28. Serebruany V.L., Miller M., Pokov A.N., et al. Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study). Am J Cardiol 2006, 97:1332-1336.
29. Sen-Banerjee S., Mir S., Lin Z., et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 2005, 112:720-726.
30. Parmar K.M., Nambudiri V., Dai G., Larman H.B., Gimbrone M.A., Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. JBiol Chem 2005, 280:26714-26719.